Continuing its downward trend, India in last 24 hours reported 55,722 fresh coronavirus infection. The total covid-19 tally now stands sat 7,550271. With 579 fatalities, the death toll has reached 1,14,610.
The number of fatalities reported in last 24 hours are the lowest in months. The active cases remained less than 8 lakh for the third consecutive day, the health ministry data showed. It also informed that India continues to report a trend of steady decline in the active cases with currently 10.45 per cent of the total cases active ini the country.
“Following the national trend, 22 states and Union territories have less than 20,000 active cases. 13 states and Union territories have more than 20,000 but less than 50,000 active cases, while three states and Union territories have more than 50,000 active cases,” the health ministry said in a press release on Sunday.
India’s total recovered cases stand at 6,663,608 currently with the national recovery rate at 80.25 per cent.
Here’re some more updates related to the coronavirus:
*Schools across UP, Sikkim and Punjab resume after 7 months. States have released strict guidelines to curb the spread of the virus.
*A total of 9,50,83,976 samples were tested for Covid-19 up to 18th October. Of these, 8,59,786 samples were tested yesterday: ICMR
*Health Minister Harsh Vardhan in his Sunday Samvaad informed that there are no community transmission across the country, except in a few districts.
*The panel appointed by government has said that India could get rid of the virus by the end of February. It also said that more than 30 per cent of Indians have developed antibodies.
*Experts have said that UK needs three-week lockdown for covid reset.
*Covid-19 is additional layer to ‘gender equality in education’ challenge: UNESCO report
*Mumbai metro to resume operation after being shut for months.
*China’s health authority found living coronavirus in the outer packaging of imported frozen marine fish in the port city of Qingado.
Covid-19 vaccine update: Serum Institute of India and Bharat Biotech will continue late stage trial of their experimental covid-10 vaccine in coming months once they get regulatory approval, Health Minster said.
It is known that Bharat Biotech was one of the first drug makers across the country to conduct successful early stage trials of indigenous covid-19 vaccine. SII, on the other hand, has been involved in conducting trials and manufacturing Oxford and AstraZeneca’s covid-19 vaccine.
Meanwhile, the global coronavirus tally has topped 40 million cases and currently stands at 40,264,218. While 30,108,031 have recovered, 1,118,167 have died so far.
